Furui Co., Ltd. announced that the company received a “Decision” from the Inner Mongolia Supervisory Authority, indicating that the company had problems with inadequate internal control over the management of overseas subsidiaries and irregular revenue accounting. The company lacks internal control and risk management systems for overseas subsidiaries, and internal departments have not carried out inspections and supervision. In terms of revenue accounting, revenue is recognized as soon as the company's drug sales leave the warehouse, resulting in inaccurate disclosure of financial information in many regular reports, and unreasonable estimation of variable consideration such as sales discounts. Wang Guanyi, chairman and general manager of the company, and Sun Xiuzhen, secretary of the board of directors and acting financial director at the time, were issued a warning letter.

Furui Co., Ltd. announced that the company received a “Decision” from the Inner Mongolia Supervisory Authority, indicating that the company had problems with inadequate internal control over the management of overseas subsidiaries and irregular revenue accounting. The company lacks internal control and risk management systems for overseas subsidiaries, and internal departments have not carried out inspections and supervision. In terms of revenue accounting, revenue is recognized as soon as the company's drug sales leave the warehouse, resulting in inaccurate disclosure of financial information in many regular reports, and unreasonable estimation of variable consideration such as sales discounts. Wang Guanyi, chairman and general manager of the company, and Sun Xiuzhen, secretary of the board of directors and acting financial director at the time, were issued a warning letter.